Trends in Infectious Diseases: Updates on Treatment & Prevention Strategies for HIV and HCV
HIV Can Be Prevented— Are You Doing Your Part?
Clinical Practice Guidelines & Recommendations
Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2018 Recommendations on the International Antiviral Society-USA Panel
Saag MS, et al. JAMA. 2018;320(4):379-396.
Preexposure Prophylaxis for the Prevention of HIV Infection: US Preventive Services Task Force Recommendation Statement.
USPSTF. JAMA. 2019;321(22):2203-2213.
Preexposure Prophylaxis for the Prevention of HIV Infection in the United States—2017 Update. Clinical Practice Guideline
Centers for Disease Control and Prevention, 2017.
Preexposure Prophylaxis for the Prevention of HIV Infection in the United States—2017 Update. Clinical Provider’s Supplement
Centers for Disease Control and Prevention, 2017.
Quick Reference Guide: Recommended Laboratory HIV Testing Algorithm for Serum or Plasma Specimens.
Centers for Disease Control and Prevention, 2018.
STD and HIV Screening Recommendations.
Centers for Disease Control and Prevention, 2015.
Clinical Resources
American Academy of HIV Medicine | Supporting the HIV Care Provider and the Profession.
Basic Statistics.
Centers for Disease Control and Prevention, April 2019.
Center of Excellence for Transgender Health.
University of California, San Francisco, School of Medicine, 2018.
Database of Antiretroviral Drug Interactions.
HIV InSite. University of California, San Francisco.
A Guide to Taking a Sexual History.
Centers for Disease Control and Prevention.
HIV Among Youth.
Centers for Disease Control and Prevention, April 2019.
HIV in the United States by Region
Centers for Disease Control and Prevention, 2018.
HIV Surveillance Report, Diagnoses of HIV Infection in the United States and Dependent Areas, 2017.
Centers for Disease Control and Prevention, 2018.
National College Health Assessment II.
American College Health Association, 2015.
PrEP Training Curriculum Modules
Developed by the South African HIV Clinicians Society, this training curriculum is for implementers rolling out PrEP. Modules are available on the PrEP Watch website.
Sexually Transmitted Diseases.
Centers for Disease Control and Prevention, 2019.
Southeast AETC (AIDS Education & Training Center Program)
Patient Resources
Centers for Disease Control and Prevention (CDC): HIV Basics.
The CDC is a division within the US Department of Health and Human Services (DHHS), the principal agency for protecting the health of all Americans. This comprehensive site provides extensive links to topics across the HIV-care continuum, including preexposure prophylaxis (PrEP).
HIV Risk Reduction Tool.
Centers for Disease Control and Prevention.
Suggested Readings
Antiretroviral prophylaxis for HIV prevention in heterosexual men and women.
Baeten JM, et al. N Engl J Med. 2012;367(5):399-410.
Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial.
Choopanya K, et al. Lancet. 2013;381(9883):2083-2090.
Implementation of a rapid entry program decreases time to viral suppression among vulnerable persons living with HIV in the southern United States.
Colasanti J, et al. Open Forum Infect Dis. 2018;5(6):ofy104.
Being PrEPared – preexposure prophylaxis and HIV disparities.
Goldstein RH, et al. N Engl J Med. 2018;379(14):1293-1295
Preexposure chemoprophylaxis for HIV prevention in men who have sex with men.
Grant RM, et al. N Engl J Med. 2010;363(27):2587-2599.
HIV Preexposure prophylaxis, by race and ethnicity – United States, 2014-2016.
Huang YA, et al. MMWR Morb Mortal Wkly Rep. 2018;67(41):1147-1150.
Efficacy, safety, and effect on sexual behaviour of on-demand pre-exposure prophylaxis for HIV in men who have sex with men: an observational cohort study.
Molina JM, et al. Lancet HIV. 2017;4(9):e402-e410.
Challenges in translating PrEP interest into uptake in an observational study of young black MSM.
Rolle CP, et al. J Acquir Immun Defic Syndr. 2017;76(3):250-258.
Willingness to use pre-exposure prophylaxis among black and white men who have sex with men in Atlanta, Georgia.
Rolle CP, et al. Int J STD AIDS. 2017;28(9):849-857.
Interactive PresentationAre you PrEP’d to Discuss Sexual Health & HIV Prevention?
This innovative live activity is designed for PCPs to practice their skills in sexual health discussions and HIV prevention via a simulated tele-visit with a standardized patient, trained to simulate the signs, symptoms, and behaviors of patients seen in daily practice. Earn 0.5 CME/CE credit. Click here for more information!
HIV Can Be Prevented— Are You Doing Your Part?
Relevant Resources
The PCPs Role in Preventing HIV
What Do You Know About PrEP?
Optimizing Use of Clinical Evidence & Pharmacoeconomic Models in Managed Care
Advances in the Diagnosis and Treatment of Nonalcoholic Steatohepatitis
What Do You Know About PrEP?
Got it? Treat it!
The Critical Role of the Community Pharmacist
Bringing Local Communities Together to Eliminate Coinfection Through Knowledge and Partnerships.
Volume 1: Rapid ART Initiation: A New Addition to the HIV-Care Tool Box
The Emerging Role of the Diabetologist
Key Issues Impacting OB/GYN Practice
An Interactive Experience Highlighting Recent Clinical Advances
Hot Topics in HBV, HCV, and NASH
Emerging Concepts in Patient Management
Building Your Understanding to Combat a Growing Problem
Volume II: Expanding Evidence for the Role of Rapid ART Initiation in HIV Practice
Why It Matters in OB/GYN Practice Today
A Treater’s Guide to Optimizing Care in the Aging Patient with Comorbidities
How the Pharmacist Can Make a Difference
Rapid Start ART — A New Model for HIV Care
Understanding the Growing Syndemic — Opioids, HCV, and HIV
Appraising the Therapeutic Armamentarium in Moderate and Severe Disease
A PrEP Primer
The PCP’s Role in HCV Elimination
What the Pharmacist Needs to Know about PrEP
The Rapid ART Standard of Care: From Evidence to Healthcare Equity
Maximizing Your Role to Impact Patient Outcomes
Building Bridges to Reach People Who Inject Drugs With the Goal to Eliminate HCV
Benefits, Barriers, & Best Practices in an Advancing Field
Practical Solutions Across the Spectrum of Care
A PEP/PrEP Training Guide for Pharmacists
An Interactive Learning Experience
A Focus on Clinical Evidence and Guideline Recommendations
A Critical Step Toward HCV Elimination
Considering the Patient, the Provider, and the Science
A Multidisciplinary Online Mini-Curriculum
Volume 1: A Guided Tour of the Evidence Driving Selection of First-line Advanced Therapies in Moderate to Severe IBD
Debates and Discussions about Monoclonal Antibody Therapies
An Update on Monoclonal Antibody Therapies
Establishing Clinical Readiness Through Mentored Learning
Interdisciplinary Strategies for Adult and Pediatric Patients
